Practical considerations in the management of adults with malignant astrocytomas

Neurologist

Volumn 2, Issue 2, 1996, Pages 130-138

  Grossman, S A ^a,b   Zeltzman, M ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anticonvulsants; Chemotherapy; Glioblastoma multiforme; Glucocorticoids; Malignant astrocytoma; Radiation therapy; Supportive care; Surgery

Indexed keywords

EID: 0342583293     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Kernohan JW, Sayre GP. Tumors of the central nervous system. Sect 10, Fasc 35. In: Atlas of tumor pathology. Washington, DC: Armed Forces Institute of Pathology, 1952.
2. Burger PC, Scheithauer BW, Vogel FS. Surgical pathology of the nervous system and its coverings. 3rd ed. New York: Churchill Livingstone, 1991.
3. Greig NH, Ries LG, Yancik R, Rapoport SI. Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst 1990;82:1621-4.
4. Grossman SA, Osman M, Hruban RH, Piantadosi S. Familial gliomas: The potential role of environmental exposures. Proc Am Soc Clin Oncol 1995;14:149.
5. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993;85:704-10.
6. Halperin EC, Burger PC, Bullard DE. The fallacy of the localized supratentorial malignant glioma. Int J Radiat Oncol Biol Phys 1988; 15:505-9.
7. Salazar OM, Rubin P. The spread of glioblastoma as a determining factor in the radiation treated volume. Int J Radiat Oncol Biol Phys 1976;1:627-37.
8. Burger PC, Heinz ER, Shibata T, Kleihves P. Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 1988;68:689-704.
9. Pedersen PH, Marienhagen K, Mork S, Bjerkvig R. Migratory pattern of fetal rat brain cells and human glioma cells in the adult rat brain. Cancer Res 1993;53:5158-65.
10. Geer CP, Grossman SA. Extracellular fluid flow along white matter tracts in brain: A potentially important mechanism for dissemination of primary brain tumors. Proc Am Soc Clin Oncol 1993;12:177.
11. Wie BA, Grossman SA, Wharam MD, Chun M. Dissemination of high grade astrocytomas along white matter tracts: Observations and therapeutic implications. Proc Am Soc Clin Oncol 1993;12:177.
12. Wood JR, Green SB, Shapiro WR. The prognostic importance of tumor size in malignant gliomas: A computed tomographic scan study by the Brain Tumor Cooperative Group. J Clin Oncol 1988;6:338-43.
13. Ammirati M, Vick N, Liao YL, Cirik I, Mikhael M. Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery 1987;21:201-6.
14. Devaux BC, O'Fallon JR, Kelly PJ. Resection, biopsy, and survival in malignant glial neoplasms: A retrospective study of clinical parameters, therapy, and outcome. J Neurosurg 1993;78:767-75.
15. Curran WJ, Scott CB, Horton J, Nelson JS, Weinstein AS, Nelson DF, et al. Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci? A report from three Radiation Therapy Oncology Group trials. J Neurooncol 1992;12:219-27.
16. Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, et al. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: Results of three consecutive Radiation Therapy Oncology Group clinical trials. Int J Radiat Oncol Biol Phys 1993;26:239-44.
17. Fadul C, Wood J, Thaler H, Galicich J, Patterson RH Jr, Posner JB. Morbidity and mortality of craniotomy for excision of supratentorial gliomas. Neurology 1988;38:1374-9.
18. Walker MD, Alexander E Jr, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: A cooperative clinical trial. J Neurosurg 1978;49:333-43.
19. Walker MD, Green SB, Byar DP, Batzdorf U, Brooks WH, Hunt WE, et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 1980;303:1323-9.
20. Walker MD, Strike TA, Sheline GE. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 1979;5:1725-31.
21. Deutsch M, Green SB, Strike TA, Burger PC, Robertson JT, Selker RG, et al. Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma. Int J Radiat Oncol Biol Phys 1989;16:1389-96.
22. Marks JE, Baglan RJ, Prassad SC, Blank WF. Cerebral radionecrosis: Incidence and risk in relation to dose, time, fractionation, and volume. Int J Radiat Oncol Biol Phys 1981;7:243-52.
23. Hochberg FH, Slotnick B. Neuropsychological impairment in astrocytoma survivors. Neurology 1980;30:172-7.
24. Gutin PH, Leibel SA, Wara WM, Choucair A, Levin VA, Philips TL, et al. Recurrent malignant gliomas: Survival following interstitial brachytherapy with high-activity iodine-125 sources. J Neurosurg 1987;67:864-73.
25. Florell RC, Macdonald DR, Irish WD, Bernstein M, Leibel SA, Gutin PH, et al. Selection bias, survival, and brachytherapy for glioma. J Neurosurg 1992;76:179-83.
26. Loeffler JS, Alexander E III, Shea WM, Wen FY, Fine HA, Kooy HM, et al. Radiosurgery as part of the initial management of patients with malignant gliomas. J Clin Oncol 1992;10:1379-85.
27. Fine HA, Dear KBG, Loeffler JS, Black PM, Canellos GD. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993;71:2585-97.
28. Levin VA, Silver P, Hannigan J, Vara WM, Gutin PH, Davis RL, et al. Superiority of post-radiation adjuvant chemotherapy with CCNU, procarbazine, and vincristine over BCNU for anaplastic gliomas. Int J Radiat Oncol Biol Phys 1990;18:321-4.
29. Grossman SA, Wharam M, Sheidler V, Zeltzman M, Zinriech J, Moynihan T, et al. BCNU/cisplatin (B/C) followed by radiation in poor prognosis patients with high grade astrocytomas (HGA). Proc Am Soc Clin Oncol 1992;11:149.
30. Gilbert MR, Lunsford LD, Kondziolka D, et al. A phase II trial of continuous infusion chemotherapy, external beam radiotherapy, and local boost radiotherapy for malignant gliomas. Proc Am Soc Clin Oncol 1992;12:176.
31. Lesser GJ, Grossman SA. Chemotherapy of malignant astrocytomas. Semin Oncol 1994;21:220-35.
32. Shapiro WR, Green SB, Burger PC, Selker RG, Van Gilder JC, Robertson JT, et al. A randomized comparison of intra-arterial venus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma. J Neurosurg 1992; 76:772-81.
33. Brem H, Piantadosi S, Burger PC, Walker M, Selker RG, Vick NA, et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 1995;345:1008-12.
34. Grossman SA, Sheidler VR, Gilbert MR. Decreased phenytoin levels in patients receiving chemotherapy: Report of a series and a review of the literature. Am J Med 1989;87:505-10.
35. Fetell MR, Grossman SA, Balmaceda C, Leu J-G, Erlanger BF, Rowinsky E, et al. Clinical and pharmacologic study of pre-irradiation Taxol administered as a 96-hour infusion in adults with newly diagnosed glioblastoma multiforme (GBM). Proc Am Soc Clin Oncol 1994;13:179.
36. Grossman SA, Burch PA. Quantitation of tumor response to anti-neoplastic therapy. Semin Oncol 1988;15:441-54.
37. Weissman DE, Dufer D, Vogel V, Abeloff MD. Corticosteroid toxicity in neuro-oncology patients. J Neurooncol 1987;5:125-8.
38. Sepkowitz KA, Brown AE, Telzak EE, et al. Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA 1992;267:823-37.
39. Dropcho EJ, Soong SJ. Steroid-induced weakness in patients with primary brain tumors. Neurology 1991;41:1235-9.
40. Tunkel RS. Physical rehabilitation. In: Abeloff MA, Armitage JO, Lichter AS, Neiderhuber JE, editors. Clinical oncology. New York: Churchill Livingstone, 1995.
41. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome. J Clin Invest 1988;82:1826-32.
42. Levi AD, Wallace MC, Bernstein M, Walters BC. Venous thromboembolism after brain tumor surgery: A retrospective review. Neurosurgery 1991;28:859-63.
43. Quevedo JF, Buckner JC, Schmidt JL, Dinapoli RP, O'Fallon JR. Thromboembolism in patients with high grade glioma. Mayo Clin Proc 1994;69:329-32.
44. Marin L, Sheidler V, Grossman SA, Wharam M. The incidence of thromboembolic complications in patients with high-grade gliomas. Proc Am Soc Clin Oncol 1990;9:368.
45. Levine MN, Gent M, Hirsh J, Arnold A, Goodyear MD, Hryniuk W, et al. The thrombogenic effect of anti-cancer drug therapy in women with stage II breast cancer. N Engl J Med 1988;318:404-7.
46. Davidson BL, Elliot CG, Lensing AW. Low accuracy of color Doppler ultrasound in the detection of proximal leg vein thrombosis in asymptomatic high-risk patients. Ann Intern Med 1992;117:735-8.
47. Anderson DR, Lensing AW, Wells PS, Levine MN, Weitz JL, Hirsch J. Limitations of impedance plethysmography in the diagnosis of clinically suspected deep-vein thrombosis. Ann Intern Med 1993; 118:25-30.
48. Norris LK, Grossman SA. Treatment of thromboembolic complications in patients with brain tumors. J Neurooncol 1994;22:127-37.
49. Woody R, Laney M. Rectal anticonvulsants in pediatric practice. Pediatr Emerg Care 1988;4:112-6.
50. DeBoer AG, Moolenaar F, de Leede LG, Breimer DD. Rectal drug administration. Clinical pharmacokinetic considerations. Clin Pharmacokinet 1982;7:285-311.